Product Images Memantine Hydrochloride

This is a description of a medication with the NDC (National Drug Code) 72606-514-02. The medication is called Memantine Hydrochloride and comes in the form of USP tablets with a strength of 5mg. The tablets should be kept out of the reach of children and stored in a tightly closed container at 20-25°C. Manufactured by Vivimed Life Sciences Private Limited in Tamilnadu, India, and distributed by Celltrion USA, Inc. Patients can refer to the package insert for prescribing and dosing information. A pharmacist should dispense the medication and patient information should be provided separately.*

The text provides a table showing the mean and standard error of the mean (SEM) change from baseline in ADCS-ADL Score after 12 weeks of treatment with either placebo or memantine HCI. The table suggests that memantine HCI led to clinical improvement compared to placebo.*

The text shows a graphical representation of the cumulative percentage of patients with Alzheimer's disease as measured by the ADCS-ADL change from baseline. The treatment options being compared are placebo and MEMANTINE HCI. The cumulative percentage of patients is represented on the y-axis, and the ADCS-ADL change from baseline is represented on the x-axis.*

The given text represents a graph showing the cumulative percentage of patients who experienced a change from baseline in SIB (Severe Impairment Battery) scores after treatment with either placebo or MEMANTINE HCI. The x-axis shows the change from baseline in SIB scores, while the y-axis represents the cumulative percentage of patients. However, the description does not provide enough information to determine the exact findings of the graph.*

This appears to be a chart depicting the cumulative percentage of patients taking either Placebo/Donepezil or Memantine HCI/Donepezil and their corresponding change from baseline in ADCS-ADL (Alzheimer's Disease Cooperative Study Activities of Daily Living) score. The chart shows a higher percentage of patients in the Memantine HCI/Donepezil group experiencing a positive change in ADCS-ADL score compared to the Placebo/Donepezil group. However, more context is needed to fully understand the chart and its implications.*

Each tablet of NDG 72606-514-04 contains 5mg of memantine hydrochloride, which is a medication used to treat certain cognitive disorders such as dementia. It should be stored in a tightly closed container at room temperature and kept out of the reach of children. Dispensing instructions are available for pharmacists to read in the package insert. The tablets are distributed by Celltrion USA, Inc. and come in a package of 500.*

This is a description for a medication with NDC 72606-515-02 code, called Memantine Hydrochloride Tablets USP. Each tablet contains 10 mg of memantine hydrochloride, which should be kept out of the reach of children and stored between 20°C to 25°C. It is necessary to dispense this medication in a tightly closed container in line with the guidelines of the United States Pharmacopeia (USP). Leaflet for patient information should be provided separately. The package insert contains dosing and prescribing information. The manufacturer is Vivimed Life Sciences Private Limited, while Celltrion USA, Inc. is responsible for distribution.*

This is a description of a medication called Memantine Hydrochloride Tablets USP. The tablets contain 10 mg of memantine hydrochloride, USP, and come in a bottle of 500 tablets. The pharmacist is directed to dispense the medication with the patient information leaflet provided separately. The tablets should be kept out of reach of children and stored in a tightly closed container at 20° to 25°C. The package insert provides dosing and full prescribing information. The medication is manufactured by Vivimed Life Sciences Private Limited in Tamilnadu, India and distributed in the USA by Celltrion USA, Inc. The text also includes manufacturing and distribution license numbers and a revision date of 10/2019.*